O	O	O	0	16	Characterization	Characterization	B-NP	NN	O	0	ROOT	O
O	O	O	17	19	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	20	23	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	24	31	nuclear	nuclear	I-NP	JJ	O	6	AMOD	O
O	O	O	32	35	and	and	I-NP	CC	O	6	AMOD	O
O	O	O	36	47	cytoplasmic	cytoplasmic	I-NP	JJ	O	7	NMOD	O
O	O	O	48	58	components	component	I-NP	NNS	O	2	PMOD	O
O	O	O	59	61	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	62	65	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	66	74	lymphoid	lymphoid	I-NP	JJ	B-protein	14	NMOD	B-protein
O	O	O	74	75	-	-	I-NP	HYPH	I-protein	14	NMOD	I-protein
O	O	O	75	83	specific	specific	I-NP	JJ	I-protein	14	NMOD	I-protein
T6	B-Entity	B-Entity	84	91	nuclear	nuclear	I-NP	JJ	I-protein	14	NMOD	I-protein
T6	I-Entity	I-Entity	92	98	factor	factor	I-NP	NN	I-protein	24	NMOD	I-protein
T6	I-Entity	I-Entity	99	101	of	of	B-PP	IN	O	14	NMOD	O
T6	I-Entity	I-Entity	102	111	activated	activate	B-NP	VBN	O	18	NMOD	O
T6	I-Entity	I-Entity	112	113	T	T	I-NP	NN	O	18	NMOD	O
T6	I-Entity	I-Entity	114	119	cells	cell	I-NP	NNS	O	15	PMOD	O
T6	I-Entity	I-Entity	120	121	(	(	O	(	O	23	DEP	O
T6	I-Entity	I-Entity	121	123	NF	NF	B-NP	NN	B-protein	22	NMOD	B-protein
T6	I-Entity	I-Entity	123	124	-	-	B-NP	HYPH	I-protein	22	P	I-protein
T6	I-Entity	I-Entity	124	126	AT	AT	I-NP	NN	I-protein	23	DEP	I-protein
T6	I-Entity	I-Entity	126	127	)	)	O	)	O	14	NMOD	O
T6	I-Entity	I-Entity	128	135	complex	complex	B-NP	NN	O	8	PMOD	O
O	O	O	135	136	.	.	O	.	O	1	P	O

O	O	O	138	141	The	The	B-NP	DT	O	6	NMOD	O
O	O	O	142	150	lymphoid	lymphoid	I-NP	JJ	B-protein	6	NMOD	B-protein
O	O	O	150	151	-	-	I-NP	HYPH	I-protein	6	NMOD	I-protein
O	O	O	151	159	specific	specific	I-NP	JJ	I-protein	6	NMOD	I-protein
T7	B-Entity	B-Entity	160	173	transcription	transcription	I-NP	NN	I-protein	6	NMOD	I-protein
T7	I-Entity	I-Entity	174	181	complex	complex	I-NP	NN	I-protein	10	NMOD	I-protein
T7	I-Entity	I-Entity	181	182	,	,	O	,	O	10	P	O
T7	I-Entity	I-Entity	183	185	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T7	I-Entity	I-Entity	185	186	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T7	I-Entity	I-Entity	186	188	AT	AT	I-NP	NN	I-protein	12	SUB	I-protein
O	O	O	188	189	,	,	O	,	O	10	P	O
O	O	O	190	192	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	193	201	involved	involve	I-VP	VBN	O	12	VC	O
O	O	O	202	204	in	in	B-PP	IN	O	13	VMOD	O
T8	B-Entity	B-Entity	205	210	early	early	B-NP	JJ	O	17	NMOD	O
T8	I-Entity	I-Entity	211	215	gene	gene	I-NP	NN	O	17	NMOD	O
O	O	O	216	226	activation	activation	I-NP	NN	O	14	PMOD	O
O	O	O	227	229	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	230	231	T	T	B-NP	NN	B-cell_type	20	NMOD	B-cell_type
O	O	O	232	237	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	O	238	241	and	and	O	CC	O	12	VMOD	O
O	O	O	242	244	is	be	B-VP	VBZ	O	12	VMOD	O
O	O	O	245	254	assembled	assemble	I-VP	VBN	O	22	VC	O
O	O	O	255	259	from	from	B-PP	IN	O	23	VMOD	O
O	O	O	260	261	a	a	B-NP	DT	O	40	NMOD	O
O	O	O	262	265	pre	pre	I-NP	AFX	B-DNA	28	NMOD	B-DNA
O	O	O	265	266	-	-	I-NP	HYPH	O	26	P	O
O	O	O	266	274	existing	exist	I-NP	VBG	O	40	NMOD	O
O	O	O	274	275	,	,	O	,	O	40	P	O
O	O	O	276	277	T	T	B-NP	NN	B-protein	34	NMOD	B-protein
O	O	O	278	282	cell	cell	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	283	293	restricted	restricted	I-NP	JJ	I-protein	34	NMOD	I-protein
O	O	O	294	305	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	34	NMOD	I-protein
O	O	O	306	312	factor	factor	I-NP	NN	I-protein	40	NMOD	I-protein
O	O	O	313	316	and	and	O	CC	O	40	NMOD	O
O	O	O	317	319	an	an	B-NP	DT	O	40	NMOD	O
O	O	O	320	329	inducible	inducible	I-NP	JJ	O	40	NMOD	O
O	O	O	330	340	ubiquitous	ubiquitous	I-NP	JJ	B-protein	40	NMOD	B-protein
O	O	O	341	348	nuclear	nuclear	I-NP	JJ	I-protein	40	NMOD	I-protein
O	O	O	349	358	component	component	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	O	359	365	within	within	B-PP	IN	O	23	VMOD	O
O	O	O	366	368	30	30	B-NP	CD	O	43	NMOD	O
O	O	O	369	372	min	min	I-NP	NN	O	41	PMOD	O
O	O	O	373	378	after	after	B-PP	IN	O	43	NMOD	O
O	O	O	379	389	activation	activation	B-NP	NN	O	44	PMOD	O
O	O	O	390	397	through	through	B-PP	IN	O	45	NMOD	O
O	O	O	398	401	the	the	B-NP	DT	O	49	NMOD	O
O	O	O	402	409	antigen	antigen	I-NP	NN	B-protein	49	NMOD	B-protein
O	O	O	410	418	receptor	receptor	I-NP	NN	I-protein	46	PMOD	I-protein
O	O	O	418	419	.	.	O	.	O	12	P	O

O	O	O	420	426	Recent	Recent	B-NP	JJ	O	2	NMOD	O
O	O	O	427	434	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	435	439	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	440	450	implicated	implicate	I-VP	VBN	O	3	VC	O
O	O	O	451	454	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	455	461	family	family	I-NP	NN	O	4	OBJ	O
O	O	O	462	464	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	465	468	AP1	AP1	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	469	476	factors	factor	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	O	477	479	as	as	B-PP	IN	O	4	VMOD	O
O	O	O	480	490	components	component	B-NP	NNS	O	10	PMOD	O
O	O	O	491	493	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	494	497	the	the	B-NP	DT	O	18	NMOD	O
T9	B-Entity	B-Entity	498	504	murine	murine	I-NP	JJ	B-protein	18	NMOD	B-protein
T9	I-Entity	I-Entity	505	507	NF	NF	I-NP	NN	I-protein	18	NMOD	I-protein
T9	I-Entity	I-Entity	507	508	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T9	I-Entity	I-Entity	508	510	AT	AT	I-NP	NN	I-protein	18	NMOD	I-protein
T9	I-Entity	I-Entity	511	518	complex	complex	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	O	518	519	.	.	O	.	O	3	P	O

O	O	O	520	528	Evidence	Evidence	B-NP	NN	O	2	SUB	O
O	O	O	529	531	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	532	540	provided	provide	I-VP	VBN	O	2	VC	O
O	O	O	541	545	here	here	B-ADVP	RB	O	3	VMOD	O
O	O	O	546	550	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	551	554	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	555	562	nuclear	nuclear	I-NP	JJ	B-protein	8	NMOD	B-protein
O	O	O	563	572	component	component	I-NP	NN	I-protein	14	SUB	I-protein
O	O	O	573	575	of	of	B-PP	IN	O	8	NMOD	O
T10	B-Entity	B-Entity	576	581	human	human	B-NP	JJ	B-protein	13	NMOD	B-protein
T10	I-Entity	I-Entity	582	584	NF	NF	I-NP	NN	I-protein	13	NMOD	I-protein
T10	I-Entity	I-Entity	584	585	-	-	O	HYPH	I-protein	13	NMOD	I-protein
T10	I-Entity	I-Entity	585	587	AT	AT	B-NP	NN	I-protein	9	PMOD	I-protein
O	O	O	588	596	contains	contain	B-VP	VBZ	O	5	SBAR	O
O	O	O	597	600	the	the	B-NP	DT	O	17	NMOD	O
T11	B-Entity	B-Entity	601	608	phorbol	phorbol	I-NP	NN	O	17	NMOD	O
T11	I-Entity	I-Entity	609	614	ester	ester	I-NP	NN	O	22	NMOD	O
T11	I-Entity	I-Entity	614	615	-	-	B-NP	HYPH	O	22	NMOD	O
T11	I-Entity	I-Entity	615	624	inducible	inducible	I-NP	JJ	O	22	NMOD	O
T11	I-Entity	I-Entity	625	638	transcription	transcription	I-NP	NN	B-protein	22	NMOD	B-protein
T11	I-Entity	I-Entity	639	645	factor	factor	I-NP	NN	I-protein	22	NMOD	I-protein
T11	I-Entity	I-Entity	646	649	AP1	AP1	I-NP	NN	B-protein	14	OBJ	B-protein
O	O	O	650	651	(	(	O	(	O	27	DEP	O
T12	B-Entity	B-Entity	651	654	Jun	Jun	B-NP	NN	B-protein	26	NMOD	B-protein
T12	I-Entity	I-Entity	654	655	/	/	O	SYM	O	26	P	O
T12	I-Entity	I-Entity	655	658	Fos	Fos	B-NP	NN	B-protein	27	DEP	B-protein
O	O	O	658	659	)	)	O	)	O	22	NMOD	O
O	O	O	659	660	.	.	O	.	O	2	P	O

O	O	O	661	663	We	We	B-NP	PRP	O	3	SUB	O
O	O	O	664	671	further	further	B-ADVP	RB	O	3	VMOD	O
O	O	O	672	684	characterize	characterize	B-VP	VBP	O	0	ROOT	O
O	O	O	685	690	which	which	B-NP	WDT	O	3	VMOD	O
O	O	O	691	694	AP1	AP1	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	695	701	family	family	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	O	702	709	members	member	I-NP	NNS	I-protein	4	NMOD	I-protein
O	O	O	710	713	can	can	B-VP	MD	O	4	SBAR	O
O	O	O	714	720	assume	assume	I-VP	VB	O	8	VC	O
O	O	O	721	725	this	this	B-NP	DT	O	11	NMOD	O
O	O	O	726	730	role	role	I-NP	NN	O	9	OBJ	O
O	O	O	730	731	.	.	O	.	O	3	P	O

O	O	O	732	740	Antisera	Antiserum	B-NP	NNS	O	4	SUB	O
O	O	O	741	743	to	to	B-PP	TO	O	1	NMOD	O
O	O	O	744	747	Fos	Fos	B-NP	NN	B-protein	2	PMOD	B-protein
O	O	O	748	756	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
T13	B-Entity	B-Entity	757	759	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T13	I-Entity	I-Entity	759	760	-	-	I-NP	HYPH	I-protein	9	P	I-protein
T13	I-Entity	I-Entity	760	762	AT	AT	I-NP	NN	I-protein	9	NMOD	I-protein
T14	I-Entity	I-Entity	763	766	DNA	DNA	I-NP	NN	O	9	NMOD	O
O	O	O	767	774	binding	binding	I-NP	NN	O	4	OBJ	O
O	O	O	775	777	as	as	B-SBAR	IN	O	4	VMOD	O
O	O	O	778	782	does	do	B-VP	VBZ	O	10	DEP	O
O	O	O	783	785	an	an	B-NP	DT	O	13	NMOD	O
T15	B-Entity	B-Entity	786	801	oligonucleotide	oligonucleotide	I-NP	NN	O	11	SUB	O
O	O	O	802	812	containing	contain	B-VP	VBG	O	13	NMOD	O
O	O	O	813	814	a	a	B-NP	DT	O	17	NMOD	O
T16	B-Entity	B-Entity	815	822	binding	bind	I-NP	VBG	B-DNA	17	NMOD	B-DNA
T16	I-Entity	I-Entity	823	827	site	site	I-NP	NN	I-DNA	14	OBJ	I-DNA
T16	I-Entity	I-Entity	828	831	for	for	B-PP	IN	O	17	NMOD	O
T16,T17	I-Entity,B-Entity	I-Entity,B-Entity	832	835	AP1	AP1	B-NP	NN	B-protein	18	PMOD	B-protein
O	O	O	835	836	.	.	O	.	O	4	P	O

O	O	O	837	849	Constitutive	Constitutive	B-NP	JJ	O	2	NMOD	O
O	O	O	850	860	expression	expression	I-NP	NN	O	17	SUB	O
O	O	O	861	863	in	in	B-ADVP	FW	O	2	NMOD	O
O	O	O	864	868	vivo	vivo	I-ADVP	FW	O	3	AMOD	O
O	O	O	869	871	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	872	875	Fos	Fos	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	O	875	876	,	,	B-PP	,	O	17	P	O
O	O	O	877	880	and	and	I-PP	CC	O	17	VMOD	O
O	O	O	881	883	to	to	B-PP	TO	O	17	VMOD	O
O	O	O	884	885	a	a	B-NP	DT	O	15	NMOD	O
O	O	O	886	892	lesser	less	I-NP	JJR	O	15	NMOD	O
O	O	O	893	899	extent	extent	I-NP	NN	O	15	NMOD	O
T1	B-Protein	B-Protein	900	903	Fra	Fra	I-NP	NNP	O	15	NMOD	O
T1	I-Protein	I-Protein	903	904	-	-	B-NP	HYPH	O	15	P	O
T1	I-Protein	I-Protein	904	905	1	1	I-NP	CD	O	9	PMOD	O
O	O	O	905	906	,	,	O	,	O	9	P	O
O	O	O	907	917	eliminates	eliminate	B-VP	VBZ	O	0	ROOT	O
O	O	O	918	921	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	922	933	requirement	requirement	I-NP	NN	O	17	OBJ	O
O	O	O	934	937	for	for	B-PP	IN	O	19	NMOD	O
O	O	O	938	945	phorbol	phorbol	B-NP	NN	O	27	NMOD	O
O	O	O	946	948	12	12	I-NP	CD	O	21	NMOD	O
O	O	O	948	949	-	-	O	HYPH	O	27	NMOD	O
O	O	O	949	958	myristate	myristate	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	959	961	13	13	I-NP	CD	I-protein	24	NMOD	I-protein
O	O	O	961	962	-	-	O	HYPH	O	24	P	O
O	O	O	962	969	acetate	acetate	B-NP	NN	O	31	NMOD	O
O	O	O	970	971	(	(	O	(	O	30	DEP	O
O	O	O	971	974	PMA	PMA	B-NP	NN	O	30	DEP	O
O	O	O	974	975	)	)	O	)	O	27	NMOD	O
O	O	O	976	987	stimulation	stimulation	B-NP	NN	O	20	PMOD	O
O	O	O	987	988	,	,	O	,	O	17	P	O
O	O	O	989	996	leaving	leave	B-VP	VBG	O	17	VMOD	O
T18	B-Entity	B-Entity	997	999	NF	NF	B-NP	NN	B-protein	36	NMOD	B-protein
T18	I-Entity	I-Entity	999	1000	-	-	B-NP	HYPH	I-protein	36	NMOD	I-protein
T18	I-Entity	I-Entity	1000	1002	AT	AT	I-NP	NN	I-protein	39	NMOD	I-protein
O	O	O	1002	1003	-	-	O	HYPH	O	39	P	O
O	O	O	1003	1011	directed	direct	B-NP	VBN	O	39	NMOD	O
O	O	O	1012	1025	transcription	transcription	I-NP	NN	O	40	SUB	O
O	O	O	1026	1036	responsive	responsive	B-ADJP	JJ	O	33	VMOD	O
O	O	O	1037	1039	to	to	B-PP	TO	O	40	AMOD	O
O	O	O	1040	1047	calcium	calcium	B-NP	NN	O	43	NMOD	O
O	O	O	1048	1057	ionophore	ionophore	I-NP	NN	O	41	PMOD	O
O	O	O	1058	1063	alone	alone	B-ADVP	RB	O	43	NMOD	O
O	O	O	1063	1064	.	.	O	.	O	17	P	O

O	O	O	1065	1079	Overexpression	Overexpression	B-NP	NN	O	12	SUB	O
O	O	O	1080	1082	of	of	B-PP	IN	O	1	NMOD	O
T2	B-Protein	B-Protein	1083	1087	cJun	cJun	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	1088	1090	or	or	I-NP	CC	O	5	NMOD	O
T3	B-Protein	B-Protein	1091	1095	JunD	JunD	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	1095	1096	,	,	O	,	O	9	P	O
O	O	O	1097	1100	but	but	O	CC	O	9	NMOD	O
O	O	O	1101	1104	not	not	O	RB	O	7	DEP	O
T4	B-Protein	B-Protein	1105	1109	JunB	JunB	B-NP	NN	B-protein	2	PMOD	B-protein
O	O	O	1109	1110	,	,	O	,	O	1	P	O
O	O	O	1111	1115	also	also	B-ADVP	RB	O	12	VMOD	O
O	O	O	1116	1126	eliminates	eliminate	B-VP	VBZ	O	0	ROOT	O
O	O	O	1127	1130	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	1131	1142	requirement	requirement	I-NP	NN	O	12	OBJ	O
O	O	O	1143	1146	for	for	B-PP	IN	O	14	NMOD	O
O	O	O	1147	1150	PMA	PMA	B-NP	NN	O	15	PMOD	O
O	O	O	1150	1151	,	,	O	,	O	12	P	O
O	O	O	1152	1162	indicating	indicate	B-VP	VBG	O	12	VMOD	O
O	O	O	1163	1167	that	that	B-SBAR	IN	O	18	VMOD	O
O	O	O	1168	1172	many	many	B-NP	JJ	O	30	NMOD	O
O	O	O	1173	1176	but	but	I-NP	CC	O	30	NMOD	O
O	O	O	1177	1180	not	not	I-NP	RB	O	21	DEP	O
O	O	O	1181	1184	all	all	B-NP	DT	O	24	NMOD	O
O	O	O	1185	1188	Jun	Jun	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	1188	1189	-	-	B-NP	HYPH	O	24	P	O
O	O	O	1190	1193	and	and	I-NP	CC	O	27	NMOD	O
O	O	O	1194	1197	Fos	Fos	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	1197	1198	-	-	B-NP	HYPH	O	30	NMOD	O
O	O	O	1198	1205	related	relate	I-NP	VBN	O	30	NMOD	O
O	O	O	1206	1214	proteins	protein	I-NP	NNS	O	32	SUB	O
O	O	O	1215	1227	functionally	functionally	B-ADVP	RB	O	32	VMOD	O
O	O	O	1228	1236	activate	activate	B-VP	VBP	O	19	SBAR	O
T19	B-Entity	B-Entity	1237	1239	NF	NF	B-NP	NN	B-protein	35	NMOD	B-protein
T19	I-Entity	I-Entity	1239	1240	-	-	B-NP	HYPH	I-protein	35	NMOD	I-protein
T19	I-Entity	I-Entity	1240	1242	AT	AT	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	O	1242	1243	-	-	B-NP	HYPH	O	38	NMOD	O
O	O	O	1243	1252	dependent	dependent	I-NP	JJ	O	38	NMOD	O
O	O	O	1253	1266	transcription	transcription	I-NP	NN	O	32	OBJ	O
O	O	O	1267	1269	in	in	B-PP	IN	O	32	VMOD	O
O	O	O	1270	1273	the	the	B-NP	DT	O	41	NMOD	O
O	O	O	1274	1282	presence	presence	I-NP	NN	O	39	PMOD	O
O	O	O	1283	1285	of	of	B-PP	IN	O	41	NMOD	O
O	O	O	1286	1289	the	the	B-NP	DT	O	45	NMOD	O
O	O	O	1290	1301	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	45	NMOD	B-protein
O	O	O	1302	1311	component	component	I-NP	NN	I-protein	42	PMOD	I-protein
O	O	O	1311	1312	.	.	O	.	O	12	P	O

T20	B-Entity	B-Entity	1313	1315	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T20	I-Entity	I-Entity	1315	1316	-	-	I-NP	HYPH	I-protein	5	NMOD	I-protein
T20	I-Entity	I-Entity	1316	1318	AT	AT	I-NP	NN	I-protein	5	NMOD	I-protein
T21	I-Entity	I-Entity	1319	1322	DNA	DNA	I-NP	NN	O	5	NMOD	O
O	O	O	1323	1330	binding	binding	I-NP	NN	O	6	SUB	O
O	O	O	1331	1334	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	1335	1337	be	be	I-VP	VB	O	6	VC	O
O	O	O	1338	1351	reconstituted	reconstitute	I-VP	VBN	O	7	VC	O
O	O	O	1352	1354	in	in	B-ADVP	FW	O	8	VMOD	O
O	O	O	1355	1360	vitro	vitro	I-ADVP	FW	O	9	AMOD	O
O	O	O	1361	1366	using	use	B-VP	VBG	O	8	VMOD	O
O	O	O	1367	1371	semi	semi	B-NP	AFX	O	16	NMOD	O
O	O	O	1371	1372	-	-	I-NP	HYPH	B-protein	16	NMOD	B-protein
O	O	O	1372	1380	purified	purify	B-NP	VBN	I-protein	16	NMOD	I-protein
O	O	O	1381	1384	AP1	AP1	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	1385	1393	proteins	protein	I-NP	NNS	I-protein	11	OBJ	I-protein
O	O	O	1394	1399	mixed	mix	B-VP	VBN	O	16	NMOD	O
O	O	O	1400	1404	with	with	B-PP	IN	O	17	VMOD	O
O	O	O	1405	1412	cytosol	cytosol	B-NP	NN	O	18	PMOD	O
O	O	O	1413	1417	from	from	B-PP	IN	O	19	NMOD	O
O	O	O	1418	1419	T	T	B-NP	NN	B-cell_type	22	NMOD	B-cell_type
O	O	O	1420	1431	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	O	1431	1432	.	.	O	.	O	6	P	O

O	O	O	1433	1436	Fos	Fos	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	1437	1445	proteins	protein	I-NP	NNS	I-protein	3	SUB	I-protein
O	O	O	1446	1449	are	be	B-VP	VBP	O	18	VMOD	O
O	O	O	1450	1453	not	not	I-VP	RB	O	3	VMOD	O
O	O	O	1454	1460	needed	need	I-VP	VBN	O	3	VC	O
O	O	O	1461	1464	for	for	B-PP	IN	O	5	VMOD	O
O	O	O	1465	1469	this	this	B-NP	DT	O	8	NMOD	O
O	O	O	1470	1484	reconstitution	reconstitution	I-NP	NN	O	6	PMOD	O
O	O	O	1484	1485	,	,	O	,	O	18	P	O
O	O	O	1486	1489	and	and	O	CC	O	18	VMOD	O
O	O	O	1490	1498	although	although	B-SBAR	IN	O	18	VMOD	O
T5	B-Protein	B-Protein	1499	1503	JunB	JunB	B-NP	NN	B-protein	13	SUB	B-protein
O	O	O	1504	1506	is	be	B-VP	VBZ	O	11	SBAR	O
O	O	O	1507	1510	not	not	O	RB	O	13	VMOD	O
O	O	O	1511	1521	functional	functional	B-ADJP	JJ	O	13	PRD	O
O	O	O	1521	1522	,	,	O	,	O	18	P	O
O	O	O	1523	1525	it	it	B-NP	PRP	O	18	SUB	O
O	O	O	1526	1529	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	1530	1541	participate	participate	I-VP	VB	O	18	VC	O
O	O	O	1542	1544	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	1545	1548	the	the	B-NP	DT	O	27	NMOD	O
T22	B-Entity	B-Entity	1549	1551	NF	NF	I-NP	NN	B-protein	27	NMOD	B-protein
T22	I-Entity	I-Entity	1551	1552	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T22	I-Entity	I-Entity	1552	1554	AT	AT	I-NP	NN	I-protein	27	NMOD	I-protein
T23	I-Entity	I-Entity	1555	1558	DNA	DNA	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	1559	1566	binding	binding	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	1567	1574	complex	complex	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	O	1574	1575	.	.	O	.	O	18	P	O

O	O	O	1576	1583	Finally	Finally	B-ADVP	RB	O	4	VMOD	O
O	O	O	1583	1584	,	,	O	,	O	4	P	O
O	O	O	1585	1587	we	we	B-NP	PRP	O	4	SUB	O
O	O	O	1588	1592	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	1593	1602	partially	partially	I-VP	RB	O	4	VMOD	O
O	O	O	1603	1611	purified	purify	I-VP	VBN	O	4	VC	O
O	O	O	1612	1615	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1616	1627	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	9	NMOD	B-protein
O	O	O	1628	1637	component	component	I-NP	NN	I-protein	6	OBJ	I-protein
O	O	O	1638	1640	of	of	B-PP	IN	O	9	NMOD	O
T24	B-Entity	B-Entity	1641	1643	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T24	I-Entity	I-Entity	1643	1644	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T24	I-Entity	I-Entity	1644	1646	AT	AT	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	O	1647	1650	and	and	I-NP	CC	O	4	VMOD	O
O	O	O	1651	1655	show	show	I-NP	NN	O	4	VMOD	O
O	O	O	1656	1658	by	by	B-PP	IN	O	15	VMOD	O
O	O	O	1659	1666	elution	elution	B-NP	NN	O	19	NMOD	O
O	O	O	1667	1670	and	and	I-NP	CC	O	19	NMOD	O
O	O	O	1671	1683	renaturation	renaturation	I-NP	NN	O	16	PMOD	O
O	O	O	1684	1688	from	from	B-PP	IN	O	19	NMOD	O
O	O	O	1689	1692	SDS	SDS	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	1692	1693	-	-	B-NP	HYPH	O	26	P	O
O	O	O	1693	1707	polyacrylamide	polyacrylamide	I-NP	NN	O	26	NMOD	O
O	O	O	1708	1711	gel	gel	I-NP	NN	O	26	NMOD	O
O	O	O	1712	1727	electrophoresis	electrophoresis	I-NP	NN	O	26	NMOD	O
O	O	O	1728	1732	gels	gel	I-NP	NNS	O	20	PMOD	O
O	O	O	1733	1737	that	that	B-NP	IN	O	15	VMOD	O
O	O	O	1738	1740	it	it	B-NP	PRP	O	29	SUB	O
O	O	O	1741	1744	has	have	B-VP	VBZ	O	27	SBAR	O
O	O	O	1745	1746	a	a	B-NP	DT	O	32	NMOD	O
O	O	O	1747	1756	molecular	molecular	I-NP	JJ	O	32	NMOD	O
O	O	O	1757	1761	mass	mass	I-NP	NN	O	37	NMOD	O
O	O	O	1762	1769	between	between	B-PP	IN	O	37	NMOD	O
O	O	O	1770	1772	94	94	B-NP	CD	O	33	AMOD	O
O	O	O	1773	1776	and	and	I-NP	CC	O	33	AMOD	O
O	O	O	1777	1780	116	116	I-NP	CD	O	33	AMOD	O
O	O	O	1781	1784	kDa	kDa	I-NP	NN	O	29	OBJ	O
O	O	O	1785	1788	and	and	O	CC	O	29	VMOD	O
O	O	O	1789	1792	may	may	B-VP	MD	O	29	VMOD	O
O	O	O	1793	1797	have	have	I-VP	VB	O	39	VC	O
O	O	O	1798	1806	multiple	multiple	B-NP	JJ	O	43	AMOD	O
O	O	O	1807	1821	differentially	differentially	I-NP	RB	O	43	AMOD	O
O	O	O	1822	1830	modified	modified	I-NP	JJ	O	44	NMOD	O
O	O	O	1831	1836	forms	form	I-NP	NNS	O	40	OBJ	O
O	O	O	1836	1837	.	.	O	.	O	4	P	O
